...
首页> 外文期刊>Journal of Medical Virology >Cellular chromosome DNA interferes with fluorescence quantitative real-time PCR detection of HBV DNA in culture medium.
【24h】

Cellular chromosome DNA interferes with fluorescence quantitative real-time PCR detection of HBV DNA in culture medium.

机译:细胞染色体DNA干扰了培养基中HBV DNA的荧光定量实时PCR检测。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fluorescence quantitative real-time PCR (FQ-PCR) is a recently developed technique increasingly used for clinical diagnosis by detection of hepatitis B virus (HBV) DNA in serum. FQ-PCR is also used in scientific research for detection of HBV DNA in cell culture. Understanding potential FQ-PCR interference factors can improve the accuracy of HBV DNA quantification in cell culture medium. HBV positive serum was diluted with culture medium to produce three test groups with HBV DNA levels of 5 x 10(7) copies/ml (high), 5 x 10(5) copies/ml (medium), and 5 x 10(3) copies/ml (low). Chromosome DNA was extracted from HepG2 cells and then added to high, medium, and low group samples at final concentrations of 0, 12.5, 25, 50, and 100 microg/ml. The samples were quantified by FQ-PCR and data were evaluated using statistical software. No marked changes were seen in the quantitative curves for high level HBV DNA samples when the samples were supplemented with 0-100 microg/ml of chromosome DNA. Interference was observed in medium level samples when 50 and 100 microg/ml of chromosome DNA was added. Interference was also observed in low level HBV DNA samples when the concentration of added chromosome DNA was greater than 25 microg/ml. The interference was eliminated when samples were digested by DNase I prior to PCR detection. In Conclusions, the presence of cellular chromosome DNA can interfere with the detection of HBV DNA by FQ-PCR. Removal of cellular chromosome DNA from culture media prior to FQ-PCR is necessary for reliable HBV DNA quantitative detection.
机译:荧光定量实时PCR(FQ-PCR)是最近开发的一种技术,通过检测血清中的乙型肝炎病毒(HBV)DNA越来越多地用于临床诊断。 FQ-PCR还用于科学研究中细胞培养物中HBV DNA的检测。了解潜在的FQ-PCR干扰因素可以提高细胞培养基中HBV DNA定量的准确性。用培养基稀释HBV阳性血清以产生三个测试组,其HBV DNA水平分别为5 x 10(7)拷贝/毫升(高),5 x 10(5)拷贝/毫升(中)和5 x 10(3) )份/毫升(低)。从HepG2细胞中提取染色体DNA,然后以0、12.5、25、50和100 microg / ml的终浓度添加到高,中和低组样品中。通过FQ-PCR对样品进行定量,并使用统计软件评估数据。当样品中添加了0-100微克/毫升的染色体DNA时,高水平HBV DNA样品的定量曲线中未见明显变化。当添加50和100微克/毫升的染色体DNA时,在中等水平的样品中观察到干扰。当添加的染色体DNA浓度大于25 microg / ml时,在低水平HBV DNA样品中也观察到干扰。当在PCR检测之前用DNase I消化样品时,干扰被消除。结论中,细胞染色体DNA的存在会干扰FQ-PCR检测HBV DNA。在进行FQ-PCR之前,必须先从培养基中去除细胞染色体DNA,才能进行可靠的HBV DNA定量检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号